The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.
Nature. 2019 Nov;575(7781):217-223. doi: 10.1038/s41586-019-1694-1. Epub 2019 Oct 30.
Nature. 2019.
PMID: 31666701
Clinical Trial.